Skip to main content
Home
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • China
  • Colombia
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom
  • USA
  • Contact us
GBT €8.76
  • Homepage
  • Products & Solutions
    MRI
    • Contrast Agents
    • Dotarem®
    • Elucirem™ (Gadopiclenol)
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • MRI Accessories
    • OptiStar® Elite
    • Ready-Box
    • Service & Support
    • Guerbet Service & Support during COVID-19
    • OptiProtect™ 3S
    • Digital Solutions
    • icobrain artificial intelligence solution
    Diagnostic Imaging Interconnected Solutions…

    Diagnostic Imaging Solutions

    Explore our Solutions
    CT
    • Contrast Agents
    • OptiRay®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • FlowSens® Syringeless injector
    • OptiVantage® Multi-use
    • OptiVantage® Single-use
    • Ready-Box
    • Service & Support
    • Guerbet Service & Support during COVID-19
    • OptiProtect™ 3S
    • Digital Solutions
    • icobrain artificial intelligence solution
    Diagnostic Imaging Interconnected Solutions…

    Diagnostic Imaging Solutions

    Explore our Solutions
    Cath Lab
    • Contrast Agents
    • OptiRay®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • Illumena® Néo
    • Ready-Box
    • Service & Support
    • Guerbet Service & Support during COVID-19
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    Diagnostic Imaging Solutions

    Explore our Solutions
    Interventional Radiology
    • Pharmaceutical Drugs
    • Lipiodol® Ultra Fluid
    • Interventional Radiology
    • Qitexio®
    Solutions d’imagerie interventionnelle

    Interventional Imaging Solutions

    Explore our Solutions
    Women's Health
    • Pharmaceutical Drugs
    • Lipiodol® Ultra Fluid
    Fertility and women's health

    Women’s Health

    Explore our Solutions
  • Events & Webinars
  • About us
    • Guerbet UK
    • Guerbet in a nutshell
    • Our History & Future
    • News
    • Pharmacovigilance
  • Insights
  • Investors
  • Careers

Get the latest news on Guerbet

  1. Homepage
  2. About us
  3. News
Guerbet'nin Türkiye'deki Varlığına İlişkin Değişiklikler…

Guerbet receives “B” rating from the CDP for actions taken to prevent global warming

Read the article
Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

Read the article
Guerbet high in the Gaïa Index for the 2nd year running

Guerbet high in the Gaïa Index for the 2nd year running

Read the article
2019 half-year results

2018 annual results

Read the article
Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Guerbet teams will attend IFFS 2019!

Read the article
Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Guerbet enriches the visitor experience at Tech Gate during ECR 2019, Vienna

Read the article
Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

ASPIRE 2019, Guerbet involved in Women’s Healthcare!

Read the article
Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

Guerbet receives CE mark approval for SeQure® and DraKon™ microcatheters for interventional imaging

Read the article
Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Guerbet a partner of the first HTID edition

Read the article
  • ‹
  • 1
  • 2
  • 3
  • 4
  • Current page5
  • 6
  • 7
  • 8
  • 9
  • ›
Image
Logo Guerbet
  • Contact us
  • Cookie Policy
  • Data Protection Policy
  • Legal Notice
  • Code of Ethics
  • Carbon Reduction Plan
Copyright © Guerbet
2026
  • LinkedIn
  • Twitter
  • Instagram
  • YouTube